Liability Risk and Insurance
US Dimension
Johnson & Johnson in US$263 million opioid settlement with State of New York
Johnson & Johnson and its US-based Janssen Pharmaceutical Companies have revealed a US$263 million settlement agreement with
the State of New York and its participating subdivisions, including Nassau County and Suffolk County, resolving their opioid-related
claims against the company. With this agreement, the company said it had been removed from the trial that had been scheduled
to begin at the end of June.